Fecal microbiota potentiate checkpoint inhibitors, unleash microbiome startups.

Microbiome companies are scrambling for a piece of the action as checkpoint inhibitors combined with fecal microbiome transplants enhance patient responses to immunotherapy. Microbiome companies are scrambling for a piece of the action as checkpoint inhibitors combined with fecal microbiome transplants enhance patient responses to immunotherapy.